MOSCOW (MRC) -- Evonik, a leading specialty chemicals manufacturer, has developed new silicone resin for high-heat applications SILIKOPHEN AC 950, said the producer on its site.
SILIKOPHEN AC 950 - the new high-temperature resistant, high-solids silicone resin from Evonik - is HAPS-free and intended to provide protective properties in industrial applications. No toxic substances release during curing, making application of SILIKOPHEN AC 950 possible in enclosed spaces. Smoke formation and VOC content are significantly lower than traditional bake-cure silicone resins, allowing SILIKOPHEN AC 950 to meet the increasing requirements for eco-friendly coatings systems.
SILIKOPHEN AC 950 cures at ambient temperature, utilizing a catalyst, which provides additional advantages. Application displays high and early resistance to aromatic and aliphatic solvents, in addition to impact resistance and non-blocking properties without a bake-cure cycle.
"Oven drying at high temperatures has natural Limits," explains Kirstin Schulz, marketing director for industrial coatings. "Our ambient-curing systems enable coating of large objects such as in industrial plants for water treatment or for energy generation."
Compared to classic bake-cure systems, energy consumption is also lower. Curing at room temperature facilitates a user friendly, economical solution to high-temperature resistant coatings.
As MRC reported earlier, in early June 2015, Evonik Industries said it had completed the acquisition of Monarch Catalyst (Dombivli, India). Evonik announced plans to acquire Monarch Catalyst in March, subject to certain closing conditions. The company employs approximately 300 people and will be renamed Evonik Catalysts India. All of Evonik’s future catalyst activities in India will be operated through the newly acquired company. Financial details of the transaction have not been disclosed.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In 2014 more than 33,000 employees generated sales of around EUR12.9 billion and an operating profit (adjusted EBITDA) of about EUR1.9 billion.
MRC